Atlas Trials

Efficacy and Tolerability Evaluation of a Topical MD Based on SHBF in Management of Radiodermatitis.

Clinical trial NCT04483856 · COMPLETED

Trial details

NCT number
NCT04483856
Sponsor
Relife Italia S.r.l.
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
RadiodermatitisDermatitis, Radiation-Induced
Start date
2020-11-02
Primary completion
2023-02-16
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.